Ondine Biomedical Inc. (OBI.L) LSE
11.00
+0(+0.00%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
11.00
+0(+0.00%)
Currency In GBp
| Market Cap | 43.23M |
| Enterprise Value | 33.63M |
| P/E Ratio | -4.53 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 50.04 |
| Price/Book Ratio | 119.74 |
| Enterprise/Revenue | 47.1 |
| Enterprise/EBITDA | -4.3 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | -11.28 |
| Operating Margin | -11.34 |
| Return On Assets | -2.19 |
| Return On Equity | -5.06 |
| Revenue | 2.05M |
| Revenue/Share | 0 |
| Gross Profit | 1.32M |
| EBITDA | -18.49M |
| Net Income | -19.1M |
| Diluted EPS | -0.07 |
| Total Cash | 5.59M |
| Total Cash/Share | 0.01 |
| Total Debt | 557,085 |
| Total Debt/Equity | 0.76 |
| Current Ratio | 0.97 |
| Book Value Per Share | 0 |
| 52-Week Change | 12.82 |
| 52-Week High | 18.5 |
| 52-Week Low | 7.5 |
| Moving Average 50 Days | 9.11 |
| Moving Average 200 Days | 12.03 |
| Average Volume | 202,406 |
| Shares Outstanding | 428.31M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |